Matthew W. Martin

956 citations

19 papers · 338 indexed · h-index 12

Co-authors: Xiaozhang Zheng Biswarup Saha Christelle Colin Domenico Coppola Srikumar Chellappan Jennifer Y. Lee Namrata Bora-Singhal Erin F. DiMauro
Topics: Protein Kinase Regulation and GTPase Signaling (4 papers)Histone Deacetylase Inhibitors Research (4 papers)Epigenetics and DNA Methylation (2 papers)
Cited by: Organic Chemistry Oncology Molecular Biology
Journals: Journal of Clinical Oncology Cancer Research Scientific Reports
Partner nations: United States United Kingdom Spain

In The Last Decade

Matthew W. Martin

19 papers receiving 333 citations

Peers

Countries citing papers authored by Matthew W. Martin

Since Specialization

Citations

This map shows the geographic impact of Matthew W. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew W. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew W. Martin more than expected).

Fields of papers citing papers by Matthew W. Martin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew W. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew W. Martin. The network helps show where Matthew W. Martin may publish in the future.

Co-authorship network of co-authors of Matthew W. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew W. Martin. A scholar is included among the top collaborators of Matthew W. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew W. Martin. Matthew W. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2 2020 ·Scientific Reports ·Namrata Bora-Singhal,(unknown),Biswarup Saha,Christelle Colin,Jennifer Y. Lee,Matthew W. Martin,Xiaozhang Zheng,Domenico Coppola,Srikumar Chellappan	72
2	Discovery and optimization of novel piperazines as potent inhibitors of fatty acid synthase (FASN) 2019 ·Bioorganic & Medicinal Chemistry Letters ·Matthew W. Martin,David R. Lancia,Hongbin Li,(unknown),Angela V. Toms,Zhongguo Wang,Kenneth W. Bair,(unknown),Shawn P. Fessler,Deepali Gotur,(unknown),Goss S. Kauffman,Mark T. Kershaw,George P. Luke,Crystal McKinnon,Lili Yao,Wei Lü,David S. Millan	13
3	Discovery of novel N-hydroxy-2-arylisoindoline-4-carboxamides as potent and selective inhibitors of HDAC11 2018 ·Bioorganic & Medicinal Chemistry Letters ·Matthew W. Martin,Jennifer Y. Lee,David R. Lancia,Pui Yee Ng,Bingsong Han,Jennifer R. Thomason,Maureen S. Lynes,C. Gary Marshall,Chiara Conti,Alan Collis,(unknown),(unknown),(unknown),Lili Yao,Xiaozhang Zheng	41
4	Abstract LB-249: HDAC11 regulates lysine acetylation of enolase 1 2018 ·Cancer Research ·Vasundhara Sharma,Agni Christodoulidou,(unknown),Aileen Y. Alontaga,(unknown),(unknown),Xiaozhang Zheng,Matthew W. Martin,Jennifer Y. Lee,(unknown),Kenneth L. Wright	2
5	Antitumor activity of osimertinib in NSCLC harboring EGFR exon 20 insertions. 2017 ·Journal of Clinical Oncology ·Jonathan W. Riess,Nicolas Floc’h,Matthew W. Martin,Jonathon P. Orme,Anna D. Staniszewska,Ludovic Ménard,Maria Emanuela Cuomo,Daniel O’Neill,Richard A. Ward,(unknown),Darren McKerrecher,Mingshan Cheng,(unknown),(unknown),Chunting Ye,James Keck,David R. Gandara,Philip C. Mack,Darren A.E. Cross	5
6	Design and Optimization of Benzopiperazines as Potent Inhibitors of BET Bromodomains 2017 ·ACS Medicinal Chemistry Letters ·David S. Millan,Katherine J. Kayser-Bricker,Matthew W. Martin,Adam C. Talbot,(unknown),Torsten Herbertz,(unknown),George P. Luke,(unknown),(unknown),(unknown),(unknown),Rachel L. Mendes,Crystal McKinnon	14
7	Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling 2016 ·Bioorganic & Medicinal Chemistry ·Longbin Liu,Matthew R. Lee,Joseph L. Kim,Douglas A. Whittington,Howard Bregman,Zihao Hua,Richard T. Lewis,Matthew W. Martin,Nobuko Nishimura,Michele Potashman,Kevin Yang,(unknown),(unknown),Linda F. Epstein,Carol Babij,Manory Fernando,Josette Carnahan,Mark H. Norman	13
8	Abstract P3-14-11: Gene-expression analyses identify altered transcription factors and supports the antitumor activity of novel bromodomain inhibitors in triple negative breast cancer 2016 ·Cancer Research ·Alberto Ocaña,Javier Pérez‐Peña,Gemma Serrano‐Heras,Verónica Corrales‐Sánchez,(unknown),(unknown),(unknown),(unknown),Matthew W. Martin,Atanasio Pandiella	1
9	1551 Patient experience of symptoms and side effects when treated with AZD9291 for advanced non-small-cell lung cancer: A qualitative interview sub-study 2015 ·European Journal of Cancer ·Anna Rydén,(unknown),Matthew W. Martin,Andrew Walding	1
10	2-Phenylamino-6-cyano-1H-benzimidazole-based isoform selective casein kinase 1 gamma (CK1γ) inhibitors 2012 ·Bioorganic & Medicinal Chemistry Letters ·Zihao Hua,Xin Huang,Howard Bregman,(unknown),Erin F. DiMauro,Elizabeth M. Doherty,Jonathan T. Goldstein,Hakan Günaydin,Hongbing Huang,(unknown),John Newcomb,Vinod F. Patel,Susan M. Turci,Jie Yan,Cindy Wilson,Matthew W. Martin	20
11	Cardiothoracic Anesthesiology Fellowship: Challenges of Training and a Novel Approach to Resident Education 2011 ·Journal of Cardiothoracic and Vascular Anesthesia ·Matthew W. Martin,(unknown),(unknown)	4
12	Update on lymphocyte specific kinase inhibitors: a patent survey 2010 ·Expert Opinion on Therapeutic Patents ·Matthew W. Martin,Michelle R. Machacek	12
13	Structural modifications of N-arylamide oxadiazoles: Identification of N-arylpiperidine oxadiazoles as potent and selective agonists of CB2 2008 ·Bioorganic & Medicinal Chemistry Letters ·Erin F. DiMauro,John L. Buchanan,Alan C. Cheng,Renee Emkey,Stephen A. Hitchcock,Liyue Huang,Ming Huang,(unknown),Josie H. Lee,Xingwen Li,Matthew W. Martin,(unknown),Ryan D. White,(unknown),Vinod F. Patel,Robert T. Fremeau	14
14	Discovery of α-amidosulfones as potent and selective agonists of CB2: Synthesis, SAR, and pharmacokinetic properties 2008 ·Bioorganic & Medicinal Chemistry Letters ·Isaac E. Marx,Erin F. DiMauro,Alan C. Cheng,Renee Emkey,Stephen A. Hitchcock,Liyue Huang,Ming Huang,(unknown),Josie H. Lee,Xingwen Li,Matthew W. Martin,Ryan D. White,Robert T. Fremeau,Vinod F. Patel	7
15	Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties 2007 ·Bioorganic & Medicinal Chemistry Letters ·Matthew W. Martin,John Newcomb,Joseph J. Nunes,Jean E. Bemis,David C. McGowan,Ryan D. White,John L. Buchanan,Erin F. DiMauro,Christina Boucher,(unknown),Faye Hsieh,Xin Huang,Josie H. Lee,Stephen E. Schneider,Susan M. Turci,Xiaotian Zhu	28
16	Discovery of 4-amino-5,6-biaryl-furo[2,3-d]pyrimidines as inhibitors of Lck: Development of an expedient and divergent synthetic route and preliminary SAR 2007 ·Bioorganic & Medicinal Chemistry Letters ·Erin F. DiMauro,John Newcomb,Joseph J. Nunes,Jean E. Bemis,Christina Boucher,John L. Buchanan,(unknown),Alan C. Cheng,(unknown),Faye Hsieh,Xin Huang,Josie H. Lee,(unknown),Matthew W. Martin,David C. McGowan,Stephen E. Schneider,Susan M. Turci,Ryan D. White,Xiaotian Zhu	37
17	Inhibition by cromoglycate and some flavonoids of nucleoside diphosphate kinase and of exocytosis from permeabilized mast cells 1995 ·British Journal of Pharmacology ·Matthew W. Martin,Antony J. O’Sullivan,Bastien D. Gomperts	17
18	Photocyclization of α,β-unsaturated amide aldehydes synthesis of jatropham 1995 ·Tetrahedron Letters ·James P. Dittami,Feng Xu,Qi Hua,Matthew W. Martin,Jon Bordner,(unknown),Jeffrey P. Kiplinger,(unknown),Robert S. Ware	26
19	Preparation of N-alkyl pyrrolidinones via photocyclization of γ-keto-α,β-unsaturated amides 1995 ·Tetrahedron Letters ·James P. Dittami,Feng Xu,Qi Hua,Matthew W. Martin,Jon Bordner,(unknown),Jeffrey P. Kiplinger,(unknown),Robert S. Ware	11

About Matthew W. Martin

Matthew W. Martin is a scholar working on Toxicology, Molecular Biology and Genetics, having authored 19 papers that have together received 338 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (4 papers), Histone Deacetylase Inhibitors Research (4 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Organic Chemistry (107 citations), Oncology (84 citations) and Molecular Biology (204 citations). Matthew W. Martin has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Xiaozhang Zheng, Biswarup Saha, Christelle Colin, Domenico Coppola, Srikumar Chellappan, Jennifer Y. Lee, Namrata Bora-Singhal, Erin F. DiMauro, Bastien D. Gomperts and Michelle R. Machacek. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact